Paper Details

  1. Home
  2. Paper Details

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.

Author: GhouriMaaz A, KovacsFlora, RobertsonLindsay

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Balloon angioplasty is a common treatment for narrowing arteries in the legs. The likelihood of the arteries becoming blocked again (restenosis/reocclusion) depends on factors like the length of the blockage, blood flow in the lower legs, severity of the disease, and other heart health risks. Blood thinners are used to help prevent re-blockage.
Paper Details　
Original Abstract of the Article :
Peripheral arterial disease (PAD) is frequently treated by balloon angioplasty. Restenosis/reocclusion of the dilated segments occurs often, depending on length of occlusion, lower leg outflow, stage of disease and presence of cardiovascular risk factors. To prevent reocclusion, patients are treated...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066628/

データ提供：米国国立医学図書館（NLM）

Preventing Restenosis After Peripheral Endovascular Treatment: A Challenge in Peripheral Arterial Disease

This review article focuses on the use of antiplatelet and anticoagulant drugs for preventing restenosis, the narrowing of a previously dilated blood vessel, after peripheral endovascular treatment for peripheral arterial disease (PAD). The authors discuss the challenges associated with restenosis and the various antithrombotic agents used to prevent it.

Imagine a desert river, where the flow of water is crucial for life. PAD disrupts this flow, causing blockages and narrowing of the blood vessels. Endovascular treatment, like clearing a blockage in the river, aims to restore blood flow. However, restenosis, like a stubborn sandbar, can obstruct the flow again.

Antithrombotic Agents: A Shield Against Restenosis

The study highlights the importance of antithrombotic agents in preventing restenosis. These medications, like skilled sandbar removers, help prevent blood clots from forming and blocking the dilated blood vessels. The authors discuss the different types of antithrombotic agents used, their mechanisms of action, and their effectiveness in preventing restenosis.

Preventing Restenosis: A Multifaceted Approach

The study emphasizes that preventing restenosis requires a multifaceted approach, including patient-specific factors, such as the length of occlusion, lower leg outflow, and cardiovascular risk factors. The choice of antithrombotic agent should be tailored to individual patient needs.

Dr. Camel's Conclusion

This review provides a comprehensive overview of antithrombotic agents used to prevent restenosis after peripheral endovascular treatment. The authors emphasize the importance of individualized treatment plans and the need for further research to optimize prevention strategies.

Date :
  1. Date Completed 2012-09-26
  2. Date Revised 2023-02-14
Further Info :

Pubmed ID

22895926

DOI: Digital Object Identifier

PMC7066628

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.